Paul Devine

Company: AstraZeneca

Job title: Associate Director

Seminars:

PANEL DISCUSSION: Choosing a Method Of Empty-Full Characterisation. How Do We Ensure Industry Standardisation? 1:30 pm

Discussing best practice for empty-full characterisations, including AUC, HPLC, and ELISAs Considering the balance of cost, accuracy, reproducibility, speed, and precision Discussing whether methods ensure GMP during commercial upscaling Risk/Benefit ratio of investing in one vs multiple analytical tools Read more

day: Day One Track B PM